| 1. |
Kanahori M, Shimada E, Matsumoto Y, Endo M, Fujiwara T, Nabeshima A, Hirose T, Kawaguchi K, Oyama R, Oda Y, Nakashima Y., Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration., Br J Cancer., 2024.01. |
| 2. |
Kawaguchi K, Miyama K, Endo M, Bise R, Kohashi K, Hirose T, Nabeshima A, Fujiwara T, Matsumoto Y, Oda Y, Nakashima Y., Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma., NPJ Precis Oncol., 2024.01. |
| 3. |
Kai K, Yamada H, Tsurui R, Sakuraba K, Fujimura K, Kawahara S, Akasaki Y, Tsushima H, Fujiwara T, Hara D, Fukushi JI, Sawa S, Nakashima Y., Synovial-tissue resident macrophages play proinflammatory functions in the pathogenesis of RA while maintaining the phenotypes in the steady state., Immunol Med, 2024.01. |
| 4. |
Arisumi S, Fujiwara T, Yasumoto K, Tsutsui T, Saiwai H, Kobayakawa K, Okada S, Zhao H, Nakashima Y., Metallothionein 3 promotes osteoclast differentiation and survival by regulating the intracellular Zn2+ concentration and NRF2 pathway., Cell Death Discov, 2023.12. |
| 5. |
Soejima Y, Fujiwara T, Fujii M, Tsushima H, Yamaguchi R, Nakashima Y, Arthroscopic Treatment of Septic Arthritis of the Ankle Caused by Group B Streptococcus: A Case Report., Am J Case Rep, 10.12659/AJCR.939719, 2023.06. |
| 6. |
Kokubu Y, Fujiwara T, Nabeshima Y, Iida K, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Older age at surgery and postoperative leg length discrepancy are risk factors for unfavourable patient-reported outcome measures of knee tumour endoprostheses following resection for musculoskeletal tumour of the lower limb, Bone Joint Open, 2023.10. |
| 7. |
Suzuki M, Asai S, Hara R, Hirano Y, Nagamine S, Kaneko T, Sakane H, Okano T, Yoshioka Y, Tsuji S, Wakabayashi H, Takakubo Y, Takemoto T, Fujibayashi T, Watanabe T, Kato T, Ishikawa H, Nasu Y, Torikai E, Kaneko A, Takagi H, Fujiwara T, Kihira D, Hattori K, Kishimoto K, Ohashi Y, Sobue Y, Yokota Y, Nishiume T, Terabe K, Takahashi N, Kojima M, Imagama S, Kojima T., Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)., J Orthop Sci, 10.1016/j.jos.2023.03.020, 2023.05. |
| 8. |
Tsutsui T, Fujiwara T, Matsumoto Y, Kimura A, Kanahori M, Arisumi S, Oyamada A, Ohishi M, Ikuta K, Tsuchiya K, Tayama N, Tomari S, Miyahara H, Mae T, Hara T, Saito T, Arizono T, Kaji K, Mawatari T, Fujiwara M, Takasaki M, Shin K, Ninomiya K, Nakaie K, Antoku Y, Iwamoto Y, Nakashima Y., Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures., Osteoporos Int, 10.1007/s00198-023-06753-3, 2023.05. |
| 9. |
Hanada M, Kadota H, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y., Immediate sciatic nerve reconstruction using an ipsilateral common peroneal nerve graft at the time of sarcoma resection., Microsurgery, 10.1002/micr.31034, 2023.03. |
| 10. |
Endo M, Kataoka T, Fujiwara T, Tsukushi S, Takahashi M, Kobayashi E, Yamada Y, Tanaka T, Nezu Y, Hiraga H, Wasa J, Nagano A, Nakano K, Nakayama R, Hamada T, Kawano M, Torigoe T, Sakamoto A, Asanuma K, Morii T, Machida R, Sekino Y, Fukuda H, Oda Y, Ozaki T, Tanaka K., Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib., BMC Cancer, 10.1186/s12885-023-10693-w, 2023.05. |
| 11. |
Kai K, Fujiwara T, Nagao Y, Oki E, Yoshizumi T, Eto M, Nakashima Y., Evaluation of bone density and skeletal muscle mass after sleeve gastrectomy using computed tomography method., Bone Rep, 10.1016/j.bonr.2023.101661, 2023.02. |
| 12. |
Tsushima H, Takahide S, Akasaki Y, Fujiwara T, Hara D, Ikemura S, Sakuraba K, Kamura S, Miyahara H, Yamada H, Fukushi JI, Nakashima Y., Is there a reduction in hip destruction under a treat-to-target strategy in patients with rheumatoid arthritis?, Mod Rheumatol, 10.1093/mr/road021, 2023.02. |
| 13. |
Toda Y, Yamamoto H, Iwasaki T, Ishihara S, Ito Y, Susuki Y, Kawaguchi K, Kinoshita I, Kiyozawa D, Yamada Y, Kohashi K, Kimura A, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Mawatari M, Oda Y, Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma., Pathol Res Pract., 2022.11. |
| 14. |
Kokubu Y, Fujiwara T, Nakagawa K, Setsu N, Endo M, Fukushi JI, Matsumoto Y, Nakashima Y., Postoperative clinical and functional outcomes in patients with tumor and tumor-like lesion of foot and ankle., J Foot Ankle Res, 10.1186/s13047-022-00582-z, 2022.10. |
| 15. |
Kimura A, Toda Y, Matsumoto Y, Yamamoto H, Yahiro K, Shimada E, Kanahori M, Oyama R, Fukushima S, Nakagawa M, Setsu N, Endo M, Fujiwara T, Matsunobu T, Oda Y, Nakashima Y., Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of bone., Sci Rep., 10.1038/s41598-022-17728-5, 2022.08. |
| 16. |
Das BK, Wang L, Fujiwara T, Zhou J, Aykin-Burns N, Krager KJ, Lan R, Mackintosh SG, Edmondson R, Jennings ML, Wang X, Feng JQ, Barrientos T, Gogoi J, Kannan A, Gao L, Xing W, Mohan S, Zhao H., Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton., Elife, 10.7554/eLife.73539., 2022.06. |
| 17. |
Ishihara S, Iwasaki T, Kohashi K, Kawaguchi K, Toda Y, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Oda Y., Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma., J Cancer Res Clin Oncol., 10.1007/s00432-022-04078-y, 2022.06. |
| 18. |
Ryunosuke Oyama, Nokitaka Setsu, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Keiichiro Iida, Akira Nabeshima, Yasuharu Nakashima, Efficacy and safety of tranexamic acid in patients undergoing surgery for bone and soft tissue tumors: a propensity score matching analysis, Jpn J Clin Oncol, 10.1093/jjco/hyac078, 2022.05. |
| 19. |
Nakagawa M, Endo M, Susuki Y, Yokoyama N, Maekawa A, Nabeshima A, Iida K, Fujiwara T, Setsu N, Matsunobu T, Matsumoto Y, Yokoyama R, Yamada Y, Kohashi K, Yamamoto H, Oda Y, Iwamoto Y, Nakashima Y., Clinical, Radiological, and Histopathological Characteristics of Periosteal Chondrosarcoma with a Focus on the Frequency of Medullary Invasion., Journal of Clinical Medicine, 2022.04. |
| 20. |
Fujiwara T, Kondo M, Yamada H, Haraguchi A, Fujimura K, Sakuraba K, Kamura S, Fukushi JI, Miyahara H, Inoue Y, Tsuru T, Shuto T, Yoshizawa S, Suematsu E, Miyamura T, Ayano M, Mitoma H, Arinobu Y, Niiro H, Ohishi M, Hirata A, Tokunaga S, Takada A, Hara D, Tsushima H, Akasaki Y, Ikemura S, Sueishi T, Toya M, Sakuragi T, Tsutsui T, Kai K, Arisumi S, Nakashima Y., Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry., Arthritis Research and Therapy, 10.1186/s13075-022-02746-5, 2022.02. |
| 21. |
Shimada E, Matsumoto Y, Nakagawa M, Susuki Y, Endo M, Setsu N, Fujiwara T, Iida K, Nabeshima A, Yahiro K, Kimura A, Hirose T, Kanahori M, Oyama R, Oda Y, Nakashima Y., Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma., British Journal of Cancer, 10.1038/s41416-021-01695-1, 2022.01. |
| 22. |
Negishi T, Matsunobu A, Endo M, Yokoyama R, Kusano S, Furubayashi N, Taguchi K, Shioyama Y, Iida K, Fujiwara T, Setsu N, Matsumoto Y, Nakashima Y, Kohashi K, Yamamoto H, Oda Y, Nakamura M., An Analysis of 20 Cases of Radiation-Associated Sarcoma, Including 4 Cases Treated by Carbon Ion Radiotherapy., Oncology, 2021.12. |
| 23. |
Ishihara S, Yamamoto H, Iwasaki T, Toda Y, Yamamoto T, Yoshimoto M, Ito Y, Susuki Y, Kawaguchi K, Kinoshita I, Yamada Y, Kohashi K, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Kakuda Y, Nakashima Y, Oda Y., Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation., Modern Pathology, 2021.11. |
| 24. |
Toda Y, Yamada Y, Kohashi K, Ishihara S, Ito Y, Susuki Y, Kawaguchi K, Kinoshita I, Kiyozawa D, Mori T, Kuboyama Y, Tateishi Y, Yamamoto H, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Mawatari M, Oda Y., Prognostic implication of desmoplastic stroma in synovial sarcoma: A histological review., Pathology, research and practice, 2021.12. |
| 25. |
Shimada E, Endo M, Matsumoto Y, Tsuchihashi K, Ito M, Kusaba H, Nabeshima A, Nawata T, Maekawa A, Matsunobu T, Setsu N, Fujiwara T, Iida K, Nakagawa M, Hirose T, Kanahori M, Oyama R, Isobe T, Ariyama H, Kohashi K, Yamamoto H, Oda Y, Iwamoto Y, Akashi K, Baba E, Nakashima Y., Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?, Journal of Clinical Medicine, 10.3390/jcm10214972, 2021.10. |
| 26. |
Ikemura S, Hagio S, Akasaki Y, Fujiwara T, Tsushima H, Nakashima Y., Frequency and risk factor analyses of bone erosion of the distal interphalangeal joint in patients with rheumatoid arthritis: a cross-sectional study., Acta Reumatologica Portuguesa, 2021.09. |
| 27. |
Kanahori M, Matsumoto Y, Fujiwara T, Kimura A, Tsutsui T, Arisumi S, Oyamada A, Ohishi M, Ikuta K, Tsuchiya K, Tayama N, Tomari S, Miyahara H, Mae T, Hara T, Saito T, Arizono T, Kaji K, Mawatari T, Fujiwara M, Takasaki M, Shin K, Ninomiya K, Nakaie K, Antoku Y, Iwamoto Y, Nakashima Y., Predictive factors of non-treatment and non-persistence to osteoporosis medication after fragility hip fractures at 3 years after discharge: a multicentre, prospective cohort study in the northern Kyushu district of Japan., Archives of Osteoporosis, 2021.09. |
| 28. |
Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Nokitaka Setsu, Toshifumi Fujiwara, Kenichiro Yahiro, Atsushi Kimura, Yasuharu Nakashima, Clinical benefits of vessel sealing system (LigaSure™) during surgery for soft tissue sarcoma: a propensity score matching analysis , Japanese Journal of Clinical Oncology, https://doi.org/10.1093/jjco/hyab083, 51, 8, 1242-1247, 2021.08. |
| 29. |
Momii K, Fujiwara T, Mae T, Tokunaga M, Iwasaki T, Shiomoto K, Kubota K, Onizuka T, Miura T, Hamada T, Nakamura T, Itokawa T, Iguchi T, Yamashita A, Kikuchi N, Nakaie K, Matsumoto Y, Nakashima Y., Risk factors for excessive postoperative sliding of femoral trochanteric fracture in elderly patients: A retrospective multicenter study., Injury, 10.1016/j.injury.2021.07.039., S0020-1383, 21, 00644-00646, 2021.08. |
| 30. |
Sakuragi T, Yamada H, Haraguchi A, Kai K, Fukushi JI, Ikemura S, Akasaki Y, Fujiwara T, Tsushima H, Tsutsui T, Kondo M, Yoshikai Y, Okada S, Nakashima Y., Autoreactivity of Peripheral Helper T Cells in the Joints of Rheumatoid Arthritis, JOURNAL OF IMMUNOLOGY, 10.4049/jimmunol.2000783, 206, 9, 2045-2051, 2021.05. |
| 31. |
Shin Ishihara, Takeshi Iwasaki, Kenichi Kohashi, Yuichi Yamada, Yu Toda, Yoshihiro Ito, Yousuke Susuki, Kengo Kawaguchi, Dai Takamatsu, Shinichiro Kawatoko, Daisuke Kiyozawa, Taro Mori, Izumi Kinoshita, Hidetaka Yamamoto, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima, Yoshinao Oda , The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 10.1007/s00432-021-03616-4, 2021.04. |
| 32. |
Yoshihiro Matsumoto, Hirokazu Saiwai, Keiichiro Iida, Seiji Okada, Makoto Endo, Nokitaka Setsu, Toshifumi Fujiwara, Kenichi Kawaguchi, Yasuharu Nakashima , Shape Factor of the Spinal Cord: A Possible Predictor of Surgical Outcome for Intradural Extramedullary Spinal Tumors in the Thoracic Spine, Global Spine J, 10.1177/2192568220982571, 2021.01. |
| 33. |
Fujiwara T, Tokuda K, Momii K, Shiomoto K, Tsushima H, Akasaki Y, Ikemura S, Fukushi JI, Maki J, Kaku N, Akahoshi T, Taguchi T, Nakashima Y, Prognostic factors for the short-term mortality of patients with rheumatoid arthritis admitted to intensive care unit, BMC Rheumatology, 10.1186/s41927-020-00164-1., 2020.12. |
| 34. |
Tsuchihashi K, Kusaba H, Yoshihiro T, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Imajima T, Shinohara Y, Ito M, Yamaga S, Tanoue K, Arimizu K, Ohmura H, Hanamura F, Yamaguchi K, Isobe T, Ariyama H, Nakashima Y, Akashi K, Baba E, Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin, SCIENTIFIC REPORTS, 10.1038/s41598-020-77898-y, 10, 1, 2020.12. |
| 35. |
Toshifumi Fujiwara, Toshihiro Ebihara, Kazuki Kitade, Nokitaka Setsu, Makoto Endo, Keiichiro Iida, Yoshihiro Matsumoto, Tomoya Matsunobu, Yoshinao Oda, Yukihide Iwamoto, Yasuharu Nakashima, Risk Factors of Periprosthetic Infection in Patients with Tumor Prostheses Following Resection for Musculoskeletal Tumor of the Lower Limb, Journal of Clinical Medicine, 10.3390/jcm9103133, 9, 10, 2020.10, Tumor prostheses for the lower limb following resection of musculoskeletal tumors is useful limb salvage management; however, as compared with routine total joint replacement, an increased incidence of deep periprosthetic infection of tumor prosthesis has been observed. The risk factors for periprosthetic infection of tumor prosthesis remain unclear. This study examines the risk factors and outcomes of periprosthetic infection. This was a retrospective observational study including 121 patients (67 males and 54 females) who underwent tumor prosthesis of the lower limb after resection of musculoskeletal tumors between 1 January 2000 and 30 November 2018. Among a total of 121 tumor prostheses, 7 were total femurs, 47 were proximal femurs, 47 were distal femurs, and 20 were proximal tibias. The incidence of postoperative infection and its risk factors were analyzed. Forty-five patients (37%) had osteosarcoma, 36 patients (30%) had bone metastasis, and 10 patients (8%) had soft-tissue tumors invading the bone. The mean operating time was 229 min, and the mean follow-up duration was 5.9 years. Deep periprosthetic infection was noted in 14 patients (12%). In the multivariate analysis, the risk factors for postoperative infection were identified as being male (hazard
ratio [HR], 11.2316; p = 0.0100), soft-tissue tumor (HR, 52.2443; p = 0.0003), long operation (HR, 1.0056; p = 0.0184), and radiotherapy (HR, 6.5683; p = 0.0476). The incidence of periprosthetic infection in our institution was similar to that of previous reports. Patients undergoing tumor prosthesis of the lower limb who were male, had a soft-tissue tumor, were predicted to have a long operation, and who underwent radiation, had an increased possibility of postoperative infection.. |
| 36. |
Yahiro K, Matsumoto Y, Yamada H, Endo M, Setsu N, Fujiwara T, Nakagawa M, Kimura A, Shimada E, Okada S, Oda Y, Nakashima Y., Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes., Cancer Immunology, Immunotherapy, 2020.05. |
| 37. |
Yoshihiro Matsumoto, Akira Matsunobu, Kenichi Kawaguchi, Mistumasa Hayashida, Keiichiro Iida, Hirokazu Saiwai, Seiji Okada, Makoto Endo, Nokitaka Setsu, Toshifumi Fujiwara, Shingo Baba, Satoshi Nomoto, Yasuharu Nakashima, Clinical results of carbon‑ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas, International Journal of Clinical Oncology, 2019.10. |
| 38. |
Kimura A, Matsumoto Y, Wakata Y, Oyamada A, Ohishi M, Fujiwara T, Ikuta K, Tsuchiya K, Tayama N, Tomari S, Miyahara H, Mae T, Hara T, Saito T, Arizono T, Kaji K, Mawatari T, Fujiwara M, Sakimura R, Shin K, Ninomiya K, Nakaie K, Antoku Y, Tokunaga S, Nakashima N, Iwamoto Y, Nakashima Y., Predictive factors of mortality of patients with fragility hip fractures at 1 year after discharge: A multicenter, retrospective study in the northern Kyushu district of Japan., J Orthop Surg (Hong Kong), 2019.09. |
| 39. |
Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I, Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma, Oncogene, 2019.10. |
| 40. |
Fujiwara T, Fujimura K, Hamai S, Kamura S, Nakashima Y, Miyahara H, Mid-term clinical outcome of constrained condylar knee prosthesis for patients with rheumatoid arthritis, Mod Rheumatol, 2018.08. |
| 41. |
Franks LN, Ford BM, Fujiwara T, Zhao H, Prather PL, The Tamoxifen Derivative Ridaifen-B is a High Affinity Selective CB2 Receptor Inverse Agonist Exhibiting Anti-Inflammatory and Anti-Osteoclastogenic Effects, Toxicol Appl Pharmacol, 2018.08. |
| 42. |
Wang L, Fang B, Fujiwara T (Co-First), Gorantla KKA, Li C, Feng JQ, Jennings ML, Zhou J, Aykin-Burns N, Zhao H, Deletion of ferroportin in murine myeloid cells increases iron accumulation and
stimulates osteoclastogenesis in vitro and in vivo
, J Biol Chem, 2018.05. |
| 43. |
Fujiwara T, Zhou J, Ye S, Zhao H, RNA-binding protein Musashi-2 induced by RANKL is critical for osteoclast survival., Cell Death Dis, 2016.07. |
| 44. |
Fujiwara T, Ye S, Castro-Gomes T, Winchell CG, Andrews NW, Voth DE, Varughese KI, Mackintosh SG, Feng Y, Pavlos N, Nakamura T, Manolagas SC, Zhao H, PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis., JCI insight, 2016.10. |
| 45. |
Ye S, Fujiwara T (Co-First), Zhou J, Varughese KI, Zhao H, LIS1 regulates osteoclastogenesis through modulation of M-CSF and RANKL signaling pathways and CDC42, Int J Biol Sci , 2016.11. |
| 46. |
Zhou J, Fujiwara T (Co-First), Ye S, Li X, Zhao H, Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2, CALCIFIED TISSUE INTERNATIONAL, 10.1007/s00223-015-9967-7, 96, 5, 465-475, 2015.05. |
| 47. |
Nabeshima A, Matsumoto Y, Fukushi J, Iura K, Matsunobu T, Endo M, Fujiwara T, Iida K, Fujiwara Y, Hatano M, Yokoyama N, Fukushima S, Oda Y, Iwamoto Y , Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways., British Journal of Cancer, 2015.02. |
| 48. |
Hatano M, Matsumoto Y, Fukushi J, Matsunobu T, Endo M, Okada S, Iura K, Kamura S, Fujiwara T, Iida K, Fujiwara Y, Nabeshima A, Yokoyama N, Fukushima S, Oda Y, Iwamoto Y , Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone., Clin Exp Metastasis., 2015.05. |
| 49. |
Zhou J, Fujiwara T (Co-First), Ye S, Li X, Zhao H, Downregulation of Notch Modulators, Tetraspanin 5 and 10, Inhibits Osteoclastogenesis in Vitro, CALCIFIED TISSUE INTERNATIONAL, 10.1007/s00223-014-9883-2, 95, 3, 209-217, 2014.09. |
| 50. |
Iida K, Fukushi J, Matsumoto Y, Oda Y, Takahashi Y, Fujiwara T, Fujiwara-Okada Y, Hatano M, Nabeshima A, Kamura S, Iwamoto Y. , miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor, CANCER CELL INTERNATIONAL, 10.1186/1475-2867-13-21, 13, 2013.03. |
| 51. |
Fujiwara-Okada Y, Matsumoto Y, Fukushi J, Setsu N, Matsuura S, Kamura S, Fujiwara T, Iida K, Hatano M, Nabeshima A, Yamada H, Ono M, Oda Y, Iwamoto Y, Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of otsteosarcoma, BRITISH JOURNAL OF CANCER, 10.1038/bjc.2012.579, 108, 4, 836-847, 2013.03. |
| 52. |
Zhou J, Ye S, Fujiwara T, Manolagas SC, Zhao H, Steap4 Plays a Critical Role in Osteoclastogenesis in Vitro by Regulating Cellular Iron/Reactive Oxygen Species (ROS) Levels and cAMP Response Element-binding Protein (CREB) Activation, JOURNAL OF BIOLOGICAL CHEMISTRY, 10.1074/jbc.M113.478750, 288, 42, 30064-30074, 2013.10. |
| 53. |
Matsumoto Y, Fujiwara T, Imamura R, Okada Y, Harimaya K, Doi T, Kawaguchi K, Okada S, Yamada Y, Oda Y, Iwamoto Y, Hematoma of the ligamentum flavum in the thoracic spine: report of two cases and possible role of the transforming growth factor beta-vascular endothelial growth factor signaling axis in its pathogenesis, Journal of orthopaedic science, 2011.08. |
| 54. |
Iida KI, Fukushi JI, Fujiwara T, Oda Y, Iwamoto Y, Adult hypophosphatasia with painful periarticular calcification treated with surgical resection, Journal of bone and mineral metabolism, 2011.12. |
| 55. |
Kamura S, Matsumoto Y, Fukushi JI, Fujiwara T, Iida K, Okada Y, Iwamoto Y, Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway, British Journal of Cancer, 2010.07. |
| 56. |
Matsumoto Y, Okada Y, Fukushi J, Kamura S, Fujiwara T, Iida K, Koga M, Matsuda S, Harimaya K, Sakamoto A, Iwamoto Y
, Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone
, Journal of orthopaedic surgery and research, 2010.11. |
| 57. |
Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M, Kuwano M, Kamura S, Iida K, Okada Y, Koga M, Iwamoto Y, Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma, American Journal of Pathology, 2011.09. |
